Shuhei Kushiyama

Clinical difference between fibroblast growth factor receptor 2 subclass, type IIIb and type IIIc, in gastric cancer

Masakazu Yashiro, Kenji Kuroda, Go Masuda et al. · Scientific Reports · 2021 · 34 citations · Full text

Medicine, Cancer Biology, Oncology +9

Asporin Expression on Stromal Cells and/or Cancer Cells Might Be A Useful Prognostic Marker in Patients with Diffuse-Type Gastric Cancer

Masakazu Yashiro, Tsuyoshi Hasegawa, Yurie Yamamoto et al. · European Surgical Research · 2021 · 25 citations · Full text

Medicine, Oncology, Pathology +17

Gastric cancer stem cells survive in stress environments via their autophagy system

Shingo Togano, Masakazu Yashiro, Go Masuda et al. · Scientific Reports · 2021 · 23 citations · Full text

Life Sciences, Cell Biology, Oncology +17

CXCR2 signaling might have a tumor-suppressive role in patients with cholangiocarcinoma

Yurie Yamamoto, Atsushi Sugimoto, Koji Maruo et al. · PLoS ONE · 2022 · 22 citations · Full text

Medicine, Cell Biology, Oncology +16

Circulating tumor cells with FGFR2 expression might be useful to identify patients with existing FGFR2‐overexpressing tumor

Kenji Kuroda, Masakazu Yashiro, Yuichiro Miki et al. · Cancer Science · 2020 · 20 citations · Full text

Medicine, Cell Biology, Oncology +16